Twist Bioscience officer proposes $57.6K share sale
The shares were acquired through compensation-related vesting, and the proposed sale includes an amount to cover a related tax obligation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Twist Bioscience Corp (TWST) officer Dennis H. Cho reported a proposed sale of 348 common shares, with an aggregate market value of $57,591.01 and an approximate sale date of September 21, 2026. The shares were acquired through restricted stock vesting on September 18, 2026, as compensation. The sale includes an amount necessary to cover a tax obligation resulting from settlement of a vested equity award distribution. Prior reported sales include 14,205 shares on June 24, August 5, and August 19, 2026.
Key Figures
Key Terms
Restricted Stock Vesting financial
Aggregate Market Value financial
vested equity award distribution financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.